BioSpace News Archive

Bio-Techne Corporation today announced that Chuck Kummeth, President and Chief Executive Officer, will present at the 2018 Stephens NY Investment Conference on Wednesday, November 7, 2018, at 10:30 a.m. EST.

DELTA 9 CANNABIS INC. (TSXV: NINE) (OTC: VRNDF) (“Delta 9" or the “Company”) is pleased to announce its production and extraction plans for 2019 as well as a status update regarding its current operational expansion.

Joined by elected leaders, and health and human services officials from throughout the region, Northwell Health and The Engel Burman Group broke ground today on “Wellbridge” – a residential treatment and research center for those struggling with opioid and other substance use disorders.

Ardelyx, Inc. (Nasdaq: ARDX), today announced the presentation of preclinical data suggesting therapeutic synergy of tenapanor in combination with sevelamer, the current standard-of-care phosphate binder treatment for hyperphosphatemia, or elevated serum phosphorus.

Hamamatsu Photonics has recently developed their smallest grating spectrometer, the SMD series mini-spectrometer C14384MA, offering high near-infrared sensitivity, compact size, light weight and low cost.

BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has appointed Alan Findlater to the newly-created role of chief commercial officer.

16 Tech Innovation District, Cook Regentec innovation space serve as backdrop for local collaborations

Amgen today announced that it will report its third quarter 2018 financial results on Tuesday, Oct. 30, 2018, after the close of the U.S. financial markets.

Columbia University Fertility Center today announced it has developed and built the first weight-based scale safety system to protect stored eggs and embryos.

At the recently concluded 2018 ACR/ARHP Annual Meeting, SRF-funded researcher Michael Whitfield, PhD, Professor of Biomedical Data Science, Geisel School of Medicine, Dartmouth College announced that he has developed a classifying tool that may predict which scleroderma patients are most likely to benefit from stem cell transplants